We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advocacy Groups Appeal to HHS to Claim Patents and Negotiate Lower Drug Prices
Advocacy Groups Appeal to HHS to Claim Patents and Negotiate Lower Drug Prices
HHS should claim five patents on Serepta Therapeutics’ Exondys 51 (eteplirsen), a drug used to treat Duchenne muscular dystrophy, and use the patents as leverage to lower the drug’s price, said six advocacy groups in a letter to Health and Human Services Secretary Alex Azar.